Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken

Poultry Science

Volumn 92, Issue 10, 2013, Pages 2651-2660

  Liang, Jinfeng ^a   Fu, Jia ^a   Kang, Haihong ^a   Lin, Jian ^a   Yu, Qinghua ^a   Yang, Qian ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Avian H5N1 influenza virus; Intranasal immunization; Toll like receptor ligand; Virus challenge

Indexed keywords

AVES; AVIAN INFLUENZA VIRUS; BACILLUS SUBTILIS; GALLUS GALLUS; ORTHOMYXOVIRIDAE;

EID: 84884329191     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2013-03193     Document Type: Article

References (42)

1. Abasht, B., M. Kaiser, and S. Lamont. 2008. Toll-like receptor gene expression in cecum and spleen of advanced intercross line chicks infected with Salmonella enterica serovar Enteritidis. Vet. Immunol. Immunopathol. 123:314-323.
2. Asahi-Ozaki, Y., S. Itamura, T. Ichinohe, P. Strong, S.-I. Tamura, H. Takahashi, H. Sawa, M. Moriyama, M. Tashiro, and T. Sata. 2006. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection. Microbes Infect. 8:2706-2714.
3. Asahi-Ozaki, Y., T. Yoshikawa, Y. Iwakura, Y. Suzuki, S. I. Tamura, T. Kurata, and T. Sata. 2004. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J. Med. Virol. 74:328-335.
4. Asanuma, H., N. B. Zamri, S.-I. Sekine, Y. Fukuyama, D. Tokuhara, R. S. Gilbert, T. Fukuiwa, T. Sata, M. Tashiro, and K. Fujihashi. 2012. A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging. Vaccine 30:803-812.
5. Asif, M., K. A. Jenkins, L. S. Hilton, W. G. Kimpton, A. G. Bean, and J. W. Lowenthal. 2004. Cytokines as adjuvants for avian vaccines. Immunol. Cell Biol. 82:638-643.
6. Barnes, A. G., V. Cerovic, P. S. Hobson, and L. S. Klavinskis. 2007. Bacillus subtilis spores: A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen. Eur. J. Immunol. 37:1538-1547.
7. Bates, J. T., A. N. Honko, A. H. Graff, N. D. Kock, and S. B. Mizel. 2008. Mucosal adjuvant activity of flagellin in aged mice. Mech. Ageing Dev. 129:271-281.
8. Brazolot Millan, C. L. B., R. Weeratna, A. M. Krieg, C.-A. Siegrist, and H. L. Davis. 1998. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95:15553-15558.
9. Brownlie, R., and B. Allan. 2011. Avian toll-like receptors. Cell Tissue Res. 343:121-130.
10. Buffa, V., K. Klein, L. Fischetti, and R. J. Shattock. 2012. Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice. PLoS ONE 7:e50529.
11. Burdin, N., C. Van Kooten, L. Galibert, J. S. Abrams, J. Wijdenes, J. Banchereau, and F. Rousset. 1995. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154:2533-2544.
12. Chang, Z. 2010. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm. Res. 59:791-808.
13. Coffman, R. L., A. Sher, and R. A. Seder. 2010. Vaccine adjuvants: Putting innate immunity to work. Immunity 33:492-503.
14. Eliasson, D. G., A. Helgeby, K. Schön, C. Nygren, K. El-Bakkouri, W. Fiers, X. Saelens, K. B. Lövgren, I. Nyström, and N. Y. Lycke. 2011. A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus. Vaccine 29:3951-3961.
15. Girard, F., P. Péry, M. Naciri, and P. Quéré. 1999. Adjuvant effect of cholera toxin on systemic and mucosal immune responses in chickens infected with E. tenella or given recombinant parasitic antigen per os. Vaccine 17:1516-1524.
16. Guangyu, Z., S. Shihui, X. W. Du Lanying, R. Zhitao, K. Zhihua, G. Yan, Y. Hong, J. Shibo, L. Yuchun, and Z. Bo-Jian. 2010. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virology Journal 7:151.
17. He, H., K. M. MacKinnon, K. J. Genovese, and M. H. Kogut. 2011. CpG oligodeoxynucleotide and double-stranded RNA synergize to enhance nitric oxide production and mRNA expression of inducible nitric oxide synthase, pro-inflammatory cytokines and chemokines in chicken monocytes. Innate Immunity 17:137-144.
18. Huang, J.-M., H. A. Hong, H. Van Tong, T. H. Hoang, A. Brisson, and S. M. Cutting. 2010. Mucosal delivery of antigens using adsorption to bacterial spores. Vaccine 28:1021-1030.
19. Ichinohe, T., S.-i. Tamura, A. Kawaguchi, A. Ninomiya, M. Imai, S. Itamura, T. Odagiri, M. Tashiro, H. Takahashi, and H. Sawa. 2007. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J. Infect. Dis. 196:1313-1320.
20. Ilyas, M., I. Hussain, M. Siddique, and M. Mahmood. 2004. An aluminium hydroxide gel adsorbed inactivated egg drop syndrome vaccine. Int. J. Poult. Sci. 3:279-283.
21. Kaisho, T., and S. Akira. 2001. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontol. Scand. 59:124-130.
22. Kang, H., H. Wang, Q. Yu, and Q. Yang. 2012. Effect of intranasal immunization with inactivated avian influenza virus on local and systemic immune responses in ducks. Poult. Sci. 91:1074-1080.
23. Keestra, A. M., M. R. de Zoete, L. I. Bouwman, M. M. Vaezirad, and J. P. van Putten. 2013. Unique features of chicken Toll-like receptors. Dev. Comp. Immunol. http://dx.doi.org/10.1016/j. dci.2013.04.009.
24. Keestra, A. M., M. R. de Zoete, L. I. Bouwman, and J. P. van Putten. 2010. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 185:460-467.
25. Klinman, D. M. 2004. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4:249-258.
26. Korteweg, C., and J. Gu. 2010. Pandemic influenza A (H1N1) virus infection and avian influenza A (H5N1) virus infection: A comparative analysis. Biochem. Cell Biol. 88:575-587.
27. Kovacs-Nolan, J., L. Latimer, A. Landi, H. Jenssen, R. Hancock, L. Babiuk, and S. van Drunen, Littel van den Hurk. 2009. The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody-and cell-mediated immune responses in mice. Vaccine 27:2055-2064.
28. Kreijtz, J., R. Fouchier, and G. Rimmelzwaan. 2011. Immune responses to influenza virus infection. Virus Res. 162:19-30.
29. Lahiri, A., P. Das, and D. Chakravortty. 2008. Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond. Vaccine 26:6777-6783.
30. Lau, Y.-F., L.-H. Tang, A. W. McCall, E.-E. Ooi, and K. Subbarao. 2010. An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigensparing effect in mice. J. Virol. 84:8639-8649.
31. Lee, S. E., S. Y. Kim, B. C. Jeong, Y. R. Kim, S. J. Bae, O. S. Ahn, J.-J. Lee, H.-C. Song, J. M. Kim, and H. E. Choy. 2006. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect. Immun. 74:694-702.
32. Moghimpour Bijani, F., J. G. Vallejo, and N. Rezaei. 2012. Toll-like receptor signaling pathways in cardiovascular diseases: Challenges and opportunities. Int. Rev. Immunol. 31:379-395.
33. Nicholson, W. L., N. Munakata, G. Horneck, H. J. Melosh, and P. Setlow. 2000. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol. Mol. Biol. Rev. 64:548-572.
34. Office International Des Epizootics (OIE). 2005. Manual of diagnostic test and vaccines for terrestrial animals. Accessed Jul. 20, 2013. http://www.oie.int/manual-of-diagnostic-tests-and-vaccines-forterrestrial-animals/.
35. Plante, M., T. Jones, F. Allard, K. Torossian, J. Gauthier, N. St-Félix, G. L. White, G. H. Lowell, and D. S. Burt. 2001. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge. Vaccine 20:218-225.
36. Salvador, A., M. Igartua, R. M. Hernández, and J. L. Pedraz. 2012. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines. Vaccine 30:589-596.
37. Schneider-Ohrum, K., B. M. Giles, H. K. Weirback, B. L. Williams, D. R. DeAlmeida, and T. M. Ross. 2011. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice. Vaccine 29:9081-9092.
38. Song, M., H. A. Hong, J.-M. Huang, C. Colenutt, D. D. Khang, N. T. Van Anh, S.-M. Park, B.-S. Shim, H. H. Song, and I. S. Cheon. 2012. Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine 30:3266-3277.
39. Steinhagen, F., T. Kinjo, C. Bode, and D. M. Klinman. 2011. TLRbased immune adjuvants. Vaccine 29:3341-3355.
40. Thompson, A. L., and H. F. Staats. 2011. Cytokines: The future of intranasal vaccine adjuvants. Clin. Dev. Immunol. http:// dx.doi.org/10.1155/2011/289597.
41. Tsujimoto, H., P. A. Efron, T. Matsumoto, R. F. Ungaro, A. Abouhamze, S. Ono, H. Mochizuki, and L. L. Moldawer. 2006. Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA. Immunol. Lett. 107:155-162.
42. Xiaowen, Z., Y. Qinghua, Z. Xiaofei, and Y. Qian. 2009. Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken. Vaccine 27:5628-5632.